Advances in Prognostic Methylation Biomarkers for Prostate Cancer

There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Dilys Lam, Susan Clark, Clare Stirzaker, Ruth Pidsley
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2020-10-01
Serija:Cancers
Teme:
DNA methylation
epigenetics
biomarkers
circulating DNA
cfDNA
prostate cancer
Online dostop:https://www.mdpi.com/2072-6694/12/10/2993
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki